Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Jaguar Health (NASDAQ:JAGX)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Jaguar Health Charts.

Jaguar Health (NASDAQ:JAGX)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Jaguar Health Charts.

Jaguar Health Inc News

Form 8-A12B - Registration of securities [Section 12(b)]
Thursday 27 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 27 February 2025 (1 week ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Monday 24 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 20 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Friday 14 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Wednesday 29 January 2025 (1 month ago) • Edgar (US Regulatory)

FILAMENT HEALTH ANNOUNCES IMPORT OF COCA LEAF FROM PERU BY JOINT VENTURE MAGDALENA BIOSCIENCES
Monday 16 December 2024 (3 months ago) • PR Newswire (Canada)

Form 8-K - Current report
Wednesday 13 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Wednesday 13 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 13 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 10 October 2024 (5 months ago) • Edgar (US Regulatory)

More Jaguar Health Inc News Articles

BNP Paribas SA Bond 4042...

Bnp Paribas null

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions